Piper Sandler Maintains Overweight on CVS Health, Raises Price Target to $94
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jessica Tassan maintains an Overweight rating on CVS Health (NYSE:CVS) and raises the price target from $93 to $94.

March 15, 2024 | 2:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler analyst Jessica Tassan maintains an Overweight rating on CVS Health and raises the price target from $93 to $94.
The increase in the price target by Piper Sandler suggests a positive outlook on CVS Health's stock, likely due to strong fundamentals or growth prospects. This analyst endorsement can positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100